Version 1
: Received: 22 May 2024 / Approved: 23 May 2024 / Online: 23 May 2024 (09:54:15 CEST)
Version 2
: Received: 23 May 2024 / Approved: 23 May 2024 / Online: 23 May 2024 (14:25:14 CEST)
How to cite:
S, B.; Zarrighalam, P.; Beak, P.; Mahapatra, P. Pathpoint® eDerma: Advancing Teledermatology - A Comprehensive Literature Review and Clinical Evaluation. Preprints2024, 2024051527. https://doi.org/10.20944/preprints202405.1527.v1
S, B.; Zarrighalam, P.; Beak, P.; Mahapatra, P. Pathpoint® eDerma: Advancing Teledermatology - A Comprehensive Literature Review and Clinical Evaluation. Preprints 2024, 2024051527. https://doi.org/10.20944/preprints202405.1527.v1
S, B.; Zarrighalam, P.; Beak, P.; Mahapatra, P. Pathpoint® eDerma: Advancing Teledermatology - A Comprehensive Literature Review and Clinical Evaluation. Preprints2024, 2024051527. https://doi.org/10.20944/preprints202405.1527.v1
APA Style
S, B., Zarrighalam, P., Beak, P., & Mahapatra, P. (2024). Pathpoint® eDerma: Advancing Teledermatology - A Comprehensive Literature Review and Clinical Evaluation. Preprints. https://doi.org/10.20944/preprints202405.1527.v1
Chicago/Turabian Style
S, B., Philip Beak and Piyush Mahapatra. 2024 "Pathpoint® eDerma: Advancing Teledermatology - A Comprehensive Literature Review and Clinical Evaluation" Preprints. https://doi.org/10.20944/preprints202405.1527.v1
Abstract
Teledermatology, the dermatological consultation and diagnosis via digital communication technologies, has become increasingly important in modern healthcare. The integration of teledermatology into clinical practice has gained significant interest, especially during the COVID-19 pandemic. Numerous studies have shown the effectiveness and reliability of teledermatology, with high levels of patient satisfaction and diagnostic accuracy. Pathpoint® eDerma is a cloud-based dermatology platform that aims to streamline the documentation and management of dermatological conditions. It offers several clinical benefits, including faster diagnosis, reduced unnecessary procedures, improved access to care, and cost savings. The platform follows a comprehensive risk management plan and complies with safety regulations. It undergoes regular recertification and reviews to ensure its safety and effectiveness. The clinical evaluation of eDerma confirms its ability to deliver significant clinical benefits while effectively mitigating risks. The benefit-risk ratio of eDerma is highly acceptable, supporting its use in clinical settings to enhance dermatological care.
Keywords
Teledermatology, SaaS Platform, Clinical Evaluation, Parameters and Risk analysis
Subject
Public Health and Healthcare, Primary Health Care
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
